EP2274325A4 - Human g-csf analogs and methods of making and using thereof - Google Patents

Human g-csf analogs and methods of making and using thereof

Info

Publication number
EP2274325A4
EP2274325A4 EP08782147A EP08782147A EP2274325A4 EP 2274325 A4 EP2274325 A4 EP 2274325A4 EP 08782147 A EP08782147 A EP 08782147A EP 08782147 A EP08782147 A EP 08782147A EP 2274325 A4 EP2274325 A4 EP 2274325A4
Authority
EP
European Patent Office
Prior art keywords
human
making
methods
csf analogs
csf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08782147A
Other languages
German (de)
French (fr)
Other versions
EP2274325A1 (en
Inventor
Darryl L Carter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nora Therapeutics Inc
Original Assignee
Nora Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nora Therapeutics Inc filed Critical Nora Therapeutics Inc
Publication of EP2274325A1 publication Critical patent/EP2274325A1/en
Publication of EP2274325A4 publication Critical patent/EP2274325A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP08782147A 2008-05-13 2008-07-21 Human g-csf analogs and methods of making and using thereof Withdrawn EP2274325A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12002208A 2008-05-13 2008-05-13
PCT/US2008/070668 WO2009139784A1 (en) 2008-05-13 2008-07-21 Human g-csf analogs and methods of making and using thereof

Publications (2)

Publication Number Publication Date
EP2274325A1 EP2274325A1 (en) 2011-01-19
EP2274325A4 true EP2274325A4 (en) 2011-05-25

Family

ID=41318962

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08782147A Withdrawn EP2274325A4 (en) 2008-05-13 2008-07-21 Human g-csf analogs and methods of making and using thereof

Country Status (2)

Country Link
EP (1) EP2274325A4 (en)
WO (1) WO2009139784A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201314452D0 (en) 2013-08-13 2013-09-25 Ostara Biomedical Ltd Embryo implantation
KR101557196B1 (en) * 2013-09-26 2015-10-06 울산대학교 산학협력단 Soluble expression and purification method of active recombinant human GCSF
GB201501302D0 (en) 2015-01-27 2015-03-11 Ostara Biomedical Ltd Embryo implantation
GB201517523D0 (en) 2015-10-05 2015-11-18 Ostara Biomedical Ltd Methods and compositions for managing reproduction

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0459630A2 (en) * 1990-04-30 1991-12-04 Zeneca Limited Polypeptides
WO2001004329A1 (en) * 1999-07-08 2001-01-18 Hanmi Pharm. Co., Ltd. Modified human granulocyte-colony stimulating factor and process for producing same
WO2005039505A2 (en) * 2003-10-24 2005-05-06 Nora, Llc Compositions and methods for healthy pregnancy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69838552T2 (en) * 1997-07-14 2008-05-21 Bolder Biotechnology, Inc., Louisville DERIVATIVES OF GROWTH HORMONE AND RELATED PROTEINS
KR100735784B1 (en) * 2005-07-20 2007-07-06 재단법인 목암생명공학연구소 Mutant of granulocyte-colony stimulating factorG-CSF and chemically conjugated polypeptide thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0459630A2 (en) * 1990-04-30 1991-12-04 Zeneca Limited Polypeptides
WO2001004329A1 (en) * 1999-07-08 2001-01-18 Hanmi Pharm. Co., Ltd. Modified human granulocyte-colony stimulating factor and process for producing same
WO2005039505A2 (en) * 2003-10-24 2005-05-06 Nora, Llc Compositions and methods for healthy pregnancy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2009139784A1 *

Also Published As

Publication number Publication date
EP2274325A1 (en) 2011-01-19
WO2009139784A1 (en) 2009-11-19

Similar Documents

Publication Publication Date Title
EP2448581A4 (en) Therapeutic compositions and related methods of use
HK1200745A1 (en) Medical connectors and methods of use
HK1210717A1 (en) Stable pharmaceutical composition and methods of using same
HUS1600057I1 (en) Methods of treatment using ammonia-scavenging drugs
IL217745A0 (en) Antiviral compounds and methods of making and using thereof
HK1173654A1 (en) Therapeutic compounds and related methods of use
EG27167A (en) Microemulsifiers and methods of making and using same
EP2621588A4 (en) Methods and compositions for disease treatment using inhalation
EP2279291A4 (en) Coferons and methods of making and using them
EP2611413A4 (en) Skin compositions and methods of use thereof
PL3208612T3 (en) Compositions and methods for the treatment of immune related diseases
IL218212A0 (en) Therapeutic methods and compositions
EP2485678A4 (en) Coferons and methods of making and using them
ZA200905741B (en) Indenoisoquinolinone analogs and methods of use thereof
HRP20181877T1 (en) Methods of treatment using ammonia-scavenging drugs
EP2618844A4 (en) Oral composition and method of forming and using same
IL215093A0 (en) Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases
EP2274325A4 (en) Human g-csf analogs and methods of making and using thereof
EP2461870A4 (en) Therapeutic compositions and methods
IL210956A0 (en) Methionine analogs and methods of using same
EP2649096A4 (en) Hemoglobin compositions and methods of use
ZA201102156B (en) Improved processing of recombinant human g-csf
TWM388323U (en) Improved structure of dental handpiece (1)
SI2330892T1 (en) Methods of treatment using ammonia-scavenging drugs
TWM388322U (en) Improved structure of dental handpiece

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100415

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

A4 Supplementary search report drawn up and despatched

Effective date: 20110426

DAX Request for extension of the european patent (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: NORA THERAPEUTICS, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20111124